According to our latest research, the global sickle cell anemia market size reached USD 2.54 billion in 2024, reflecting a robust expansion driven by advanced treatment modalities and growing awareness. The market is projected to grow at a CAGR of 13.8% from 2025 to 2033, with a forecasted value of approximately USD 7.13 billion by 2033. This growth is primarily propelled by the increasing adoption of gene therapies, improved diagnostic capabilities, and rising investments in research and development. The marketÂ’s positive trajectory is further supported by the growing prevalence of sickle cell disorders worldwide and the urgent need for effective and accessible treatments. https://growthmarketreports.com/report/sickle-cell-anemia-market-global-industry-analysis